Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 693

1.

Treatment strategies for advanced hepatocellular carcinoma: Sorafenib vs hepatic arterial infusion chemotherapy.

Saeki I, Yamasaki T, Maeda M, Hisanaga T, Iwamoto T, Fujisawa K, Matsumoto T, Hidaka I, Marumoto Y, Ishikawa T, Yamamoto N, Suehiro Y, Takami T, Sakaida I.

World J Hepatol. 2018 Sep 27;10(9):571-584. doi: 10.4254/wjh.v10.i9.571. Review.

2.

Successful Laparoscopy-Assisted Resection of the Descending Colon in a Patient with Multiple Large Renal Cysts and Stricture of the Colon due to Ischemic Colitis.

Maeda H, Okamoto K, Namikawa T, Shiga M, Fujisawa K, Tadokoro M, Hanazaki K, Kobayashi M.

Case Rep Gastroenterol. 2018 Aug 31;12(2):540-545. doi: 10.1159/000486953. eCollection 2018 May-Aug.

3.

Pathological Complete Response by S-1 Chemotherapy in Advanced Gastric Cancer.

Namikawa T, Ishida N, Tsuda S, Fujisawa K, Munekage E, Iwabu J, Munekage M, Uemura S, Tsujii S, Maeda H, Kitagawa H, Kobayashi M, Hanazaki K.

In Vivo. 2018 Sep-Oct;32(5):1211-1216. doi: 10.21873/invivo.11366.

PMID:
30150446
4.

Assessment of high fat diet-induced fatty liver in medaka.

Fujisawa K, Takami T, Fukui Y, Nagatomo T, Saeki I, Matsumoto T, Hidaka I, Yamamoto N, Okamoto T, Furutani-Seiki M, Sakaida I.

Biol Open. 2018 Aug 20. pii: bio.031534. doi: 10.1242/bio.031534. [Epub ahead of print]

5.

Spontaneous rupture of abdominal wall after breast reconstruction using deep inferior epigastric perforator flap following mastectomy for breast cancer.

Iwabu J, Namikawa T, Kitagawa H, Fujisawa K, Oki T, Ogawa M, Iwai N, Yano A, Kuriyama M, Sugimoto T, Hanazaki K.

Surg Case Rep. 2018 Jul 31;4(1):83. doi: 10.1186/s40792-018-0491-7.

6.

Fabrication and evaluation of carbonate apatite-coated calcium carbonate bone substitutes for bone tissue engineering.

Fujioka-Kobayashi M, Tsuru K, Nagai H, Fujisawa K, Kudoh T, Ohe G, Ishikawa K, Miyamoto Y.

J Tissue Eng Regen Med. 2018 Oct;12(10):2077-2087. doi: 10.1002/term.2742. Epub 2018 Aug 29.

PMID:
30058260
7.

Genome-wide association study suggests four variants influencing outcomes with ranibizumab therapy in exudative age-related macular degeneration.

Akiyama M, Takahashi A, Momozawa Y, Arakawa S, Miya F, Tsunoda T, Ashikawa K, Oshima Y, Yasuda M, Yoshida S, Enaida H, Tan X, Yanagi Y, Yasukawa T, Ogura Y, Nagai Y, Takahashi K, Fujisawa K, Inoue M, Arakawa A, Tanaka K, Yuzawa M, Kadonosono K, Sonoda KH, Ishibashi T, Kubo M.

J Hum Genet. 2018 Oct;63(10):1083-1091. doi: 10.1038/s10038-018-0493-0. Epub 2018 Jul 27.

PMID:
30054556
8.

Compositional and histological comparison of carbonate apatite fabricated by dissolution-precipitation reaction and Bio-Oss®.

Fujisawa K, Akita K, Fukuda N, Kamada K, Kudoh T, Ohe G, Mano T, Tsuru K, Ishikawa K, Miyamoto Y.

J Mater Sci Mater Med. 2018 Jul 21;29(8):121. doi: 10.1007/s10856-018-6129-2.

PMID:
30032409
9.

Syntheses and Structures of d10 Coinage Metal Complexes of Electron-Accepting Phosphine Ligands Featuring a 3,3,4,4,5,5-Hexafluorocyclopentene Framework.

Agou T, Wada N, Fujisawa K, Hosoya T, Mizuhata Y, Tokitoh N, Fukumoto H, Kubota T.

Inorg Chem. 2018 Aug 6;57(15):9105-9114. doi: 10.1021/acs.inorgchem.8b01111. Epub 2018 Jul 9.

PMID:
29984577
10.

Deferasirox, an oral iron chelator, with gemcitabine synergistically inhibits pancreatic cancer cell growth in vitro and in vivo.

Shinoda S, Kaino S, Amano S, Harima H, Matsumoto T, Fujisawa K, Takami T, Yamamoto N, Yamasaki T, Sakaida I.

Oncotarget. 2018 Jun 19;9(47):28434-28444. doi: 10.18632/oncotarget.25421. eCollection 2018 Jun 19.

11.

Successful treatment of liver metastases arising from early gastric cancer achieved clinical complete response by nivolumab.

Namikawa T, Ishida N, Tsuda S, Fujisawa K, Munekage E, Iwabu J, Munekage M, Uemura S, Tsujii S, Maeda H, Kitagawa H, Kobayashi M, Hanazaki K.

Surg Case Rep. 2018 Jul 5;4(1):71. doi: 10.1186/s40792-018-0479-3.

12.

Mitochondrial Activity and Unfolded Protein Response are Required for Neutrophil Differentiation.

Tanimura A, Miyoshi K, Horiguchi T, Hagita H, Fujisawa K, Noma T.

Cell Physiol Biochem. 2018;47(5):1936-1950. doi: 10.1159/000491464. Epub 2018 Jul 4.

13.

Effect of boron doping on the electrical conductivity of metallicity-separated single walled carbon nanotubes.

Fujisawa K, Hayashi T, Endo M, Terrones M, Kim JH, Kim YA.

Nanoscale. 2018 Jul 9;10(26):12723-12733. doi: 10.1039/c8nr02323a.

PMID:
29946630
14.

KaiC family proteins integratively control temperature-dependent UV resistance in Methylobacterium extorquens AM1.

Iguchi H, Yoshida Y, Fujisawa K, Taga H, Yurimoto H, Oyama T, Sakai Y.

Environ Microbiol Rep. 2018 Jun 14. doi: 10.1111/1758-2229.12662. [Epub ahead of print]

PMID:
29901260
15.

Superficial Spreading-type Gastric Cancer with Situs Inversus Totalis.

Namikawa T, Tsuda S, Fujisawa K, Iwabu J, Uemura S, Tsujii S, Maeda H, Kitagawa H, Kobayashi M, Hanazaki K.

In Vivo. 2018 May-Jun;32(3):685-689.

16.

Evaluation of the effects of ascorbic acid on metabolism of human mesenchymal stem cells.

Fujisawa K, Hara K, Takami T, Okada S, Matsumoto T, Yamamoto N, Sakaida I.

Stem Cell Res Ther. 2018 Apr 6;9(1):93. doi: 10.1186/s13287-018-0825-1.

17.

Clinical application of photodynamic medicine technology using light-emitting fluorescence imaging based on a specialized luminous source.

Namikawa T, Fujisawa K, Munekage E, Iwabu J, Uemura S, Tsujii S, Maeda H, Kitagawa H, Fukuhara H, Inoue K, Sato T, Kobayashi M, Hanazaki K.

Med Mol Morphol. 2018 Apr 4. doi: 10.1007/s00795-018-0190-2. [Epub ahead of print] Review.

PMID:
29619546
18.

Analysis of Metabolomic Changes in Mesenchymal Stem Cells on Treatment with Desferrioxamine as a Hypoxia Mimetic Compared with Hypoxic Conditions.

Fujisawa K, Takami T, Okada S, Hara K, Matsumoto T, Yamamoto N, Yamasaki T, Sakaida I.

Stem Cells. 2018 Aug;36(8):1226-1236. doi: 10.1002/stem.2826. Epub 2018 Apr 10.

PMID:
29577517
19.

Epstein-Barr virus-associated early gastric carcinoma with lymphoid stroma, accompanied with lymph node metastasis.

Namikawa T, Fujisawa K, Munekage E, Munekage M, Oki Y, Maeda H, Kitagawa H, Ueta H, Kobayashi M, Hanazaki K.

Mol Clin Oncol. 2018 Apr;8(4):561-566. doi: 10.3892/mco.2018.1567. Epub 2018 Feb 5.

20.

Conversion surgery after S-1 plus oxaliplatin combination chemotherapy for advanced gastric cancer with multiple liver metastases.

Namikawa T, Tsuda S, Fujisawa K, Iwabu J, Uemura S, Tsujii S, Maeda H, Kitagawa H, Kobayashi M, Hanazaki K.

Clin J Gastroenterol. 2018 Aug;11(4):297-301. doi: 10.1007/s12328-018-0842-8. Epub 2018 Mar 2.

PMID:
29500608

Supplemental Content

Loading ...
Support Center